Cargando…

Non‐neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system

BACKGROUND: Non‐neutralizing antibodies inducing complement‐dependent lysis (CDL) and antibody‐dependent cell‐mediated cytotoxicity (ADCC) activity may contribute to protection against influenza infection. We investigated CDL and ADCC responses in healthy adults randomized to receive either non‐adju...

Descripción completa

Detalles Bibliográficos
Autores principales:	Friel, Damien, Co, Mary, Ollinger, Thierry, Salaun, Bruno, Schuind, Anne, Li, Ping, Walravens, Karl, Ennis, Francis A., Vaughn, David W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767944/ https://www.ncbi.nlm.nih.gov/pubmed/32889792 http://dx.doi.org/10.1111/irv.12780

Ejemplares similares

Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials
por: van der Most, Robbert G., et al.
Publicado: (2017)

Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: An observer-blind, randomized trial()
por: Yang, William H., et al.
Publicado: (2013)

Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies
por: Garcia-Sicilia, José, et al.
Publicado: (2015)

Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: Pooled analysis of 28 clinical trials
por: Vaughn, David W, et al.
Publicado: (2014)

Influenza A(H1N1)pdm09 and postpandemic influenza in Lithuania
por: Ambrozaitis, Arvydas, et al.
Publicado: (2016)

Persistently high antibody responses after AS03-adjuvanted H1N1pdm09 vaccine: Dissecting the HA specific antibody response
por: Madsen, Anders, et al.
Publicado: (2021)

Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6–35 Months of Age: Results From a Phase 2, Randomized, Observer-blind, Multicenter, Dose-ranging Study
por: Kim, Joon Hyung, et al.
Publicado: (2021)

Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults
por: Madan, Anuradha, et al.
Publicado: (2016)

Influenza A(H1N1)pdm09 virus and asthma
por: Obuchi, Masatsugu, et al.
Publicado: (2013)

Influenza A(H1N1)pdm09 Virus in Pigs, Réunion Island
por: Cardinale, Eric, et al.
Publicado: (2012)

Effectiveness of MF59™ Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands
por: Wijnans, Leonoor, et al.
Publicado: (2013)

Neurological events related to influenza A (H1N1) pdm09
por: Cárdenas, Graciela, et al.
Publicado: (2014)

The 2015 influenza A (H1N1) pdm09 outbreak in India
por: Murhekar, Manoj, et al.
Publicado: (2016)

A(H1N1)pdm09 influenza infection: vaccine inefficiency
por: Friedman, Nehemya, et al.
Publicado: (2017)

Development of PREDAC-H1pdm to model the antigenic evolution of influenza A/(H1N1) pdm09 viruses
por: Liu, Mi, et al.
Publicado: (2023)

Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease
por: Kim, Jin Hyang, et al.
Publicado: (2016)

Immune Responses in Pigs Vaccinated with Adjuvanted and Non-Adjuvanted A(H1N1)pdm/09 Influenza Vaccines Used in Human Immunization Programmes
por: Lefevre, Eric A., et al.
Publicado: (2012)

Influenza A(H1N1)pdm09-Associated Pneumonia Deaths in Thailand
por: Bunthi, Charatdao, et al.
Publicado: (2013)

The hemagglutinin of the influenza A(H1N1)pdm09 is mutating towards stability
por: Castelán-Vega, Juan A, et al.
Publicado: (2014)

Fatal Influenza A(H1N1)pdm09 Encephalopathy in Immunocompetent Man
por: Simon, Marie, et al.
Publicado: (2013)

Virological characterization of influenza H1N1pdm09 in Vietnam, 2010-2013
por: Nguyen, Hang K L, et al.
Publicado: (2015)

Influenza A(H1N1)pdm09-related pneumonia and other complications
por: Viasus, Diego, et al.
Publicado: (2012)

Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons
por: Monamele, Chavely Gwladys, et al.
Publicado: (2019)

No Association between 2008–09 Influenza Vaccine and Influenza A(H1N1)pdm09 Virus Infection, Manitoba, Canada, 2009
por: Mahmud, Salaheddin M., et al.
Publicado: (2012)

Responses to A(H1N1)pdm09 Influenza Vaccines in Participants Previously Vaccinated With Seasonal Influenza Vaccine: A Randomized, Observer-Blind, Controlled Study
por: Roy-Ghanta, Sumita, et al.
Publicado: (2014)

Use of Intravenous Peramivir for Treatment of Severe Influenza A(H1N1)pdm09
por: Louie, Janice K., et al.
Publicado: (2012)

Influenza A(H1N1)pdm09 Virus Infection in Giant Pandas, China
por: Li, Desheng, et al.
Publicado: (2014)

Cerebellitis Associated with Influenza A(H1N1)pdm09, United States, 2013
por: Sfeir, Maroun M., et al.
Publicado: (2014)

Influenza A(H1N1)pdm09 virus infection in marine mammals in California
por: Boyce, Walter M, et al.
Publicado: (2013)

Analysis of Adaptation Mutants in the Hemagglutinin of the Influenza A(H1N1)pdm09 Virus
por: Jiménez-Alberto, Alicia, et al.
Publicado: (2013)

Estimation of outbreak severity and transmissibility: Influenza A(H1N1)pdm09 in households
por: House, Thomas, et al.
Publicado: (2012)

Coinfection with influenza A(H1N1)pdm09 and dengue virus in fatal cases
por: Perdigão, Anne Carolinne Bezerra, et al.
Publicado: (2016)

The new pandemic influenza A/(H1N1)pdm09 virus: is it really "new"?
por: Baldo, V., et al.
Publicado: (2016)

Influenza A(H1N1)pdm09 epidemiology in the Eastern Province of Saudi Arabia
por: Rabaan, Ali A., et al.
Publicado: (2018)

Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews
por: Juvet, Lene Kristine, et al.
Publicado: (2021)

Understanding the Variability of Certain Biological Properties of H1N1pdm09 Influenza Viruses
por: Al Farroukh, Mohammad, et al.
Publicado: (2022)

Effectiveness of A(H1N1)pdm09 Influenza Vaccine in Adults Recommended for Annual Influenza Vaccination
por: Gefenaite, Giedre, et al.
Publicado: (2013)

Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies
por: Gao, Jin, et al.
Publicado: (2019)

Screening for Influenza A(H1N1)pdm09, Auckland International Airport, New Zealand
por: Hale, Michael J., et al.
Publicado: (2012)

Lessons Learned from Influenza A(H1N1)pdm09 Pandemic Response in Thailand
por: Ungchusak, Kumnuan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vuof96fgo9k5mjv8db3o6aapt2